TALARIS THERAPEUTICS INC - COM (TALS)

CUSIP: 87410C104

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
26,938,002
Share change
+1,066,811
Total reported value
$411,835,838
Price per share
$15.29
Number of holders
50
Value change
+$16,589,774
Number of buys
32
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 87410C104?
CUSIP 87410C104 identifies TALS - TALARIS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TALARIS THERAPEUTICS INC - COM (TALS) as of Q4 2021

As of 31 Dec 2021, TALARIS THERAPEUTICS INC - COM (TALS) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,938,002 shares. The largest 10 holders included Blackstone Inc, VIKING GLOBAL INVESTORS LP, CITADEL ADVISORS LLC, BlackRock Inc., Artal Group S.A., EVENTIDE ASSET MANAGEMENT, LLC, Cormorant Asset Management, LP, VANGUARD GROUP INC, HHLR ADVISORS, LTD., and Aisling Capital Management LP. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.